Meclonazepam
From Wikipedia, the free encyclopedia
Meclonazepam
|
|
Systematic (IUPAC) name | |
(3S)-5-(2-chlorophenyl)-3-methyl-7-nitro-1,3-dihydro-1,4-benzodiazepin-2-one | |
Identifiers | |
CAS number | |
ATC code | ? |
PubChem | |
Chemical data | |
Formula | C16H12ClN3O3 |
Mol. mass | 329.74 |
Pharmacokinetic data | |
Bioavailability | ? |
Metabolism | ? |
Half life | ? |
Excretion | ? |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status | |
Routes | ? |
Meclonazepam ((S)-3-methylclonazepam) is a drug which is a benzodiazepine derivative similar in structure to clonazepam. It has sedative and anxiolytic actions like those of other benzodiazepines,[1] and also has anti-parasitic effects against the parasitic worm Schistosoma mansoni.[2]
[edit] References
- ^ Ansseau M, Doumont A, Thiry D, von Frenckell R, Collard J. Initial study of methylclonazepam in generalized anxiety disorder. Evidence for greater power in the cross-over design. Psychopharmacology (Berlin). 1985;87(2):130-5.
- ^ O'Boyle C, Lambe R, Darragh A. Central effects in man of the novel schistosomicidal benzodiazepine meclonazepam. European Journal of Clinical Pharmacology. 1985;29(1):105-8.
|